Free Trial

Sepio Capital LP Acquires 7,403 Shares of Dolby Laboratories $DLB

Dolby Laboratories logo with Consumer Discretionary background

Key Points

  • Sepio Capital LP increased its stake in Dolby Laboratories by 68.6% in Q1, owning 18,188 shares now valued at $1,461,000.
  • Insider sales included SVP Shriram Revankar selling 7,000 shares and CEO Kevin J. Yeaman selling 25,000 shares, decreasing their holdings by 9.04% and 17.89% respectively.
  • Dolby Laboratories declared a quarterly dividend of $0.33 per share, yielding 1.8%, indicating a healthy dividend payout ratio of 48.35%.
  • Interested in Dolby Laboratories? Here are five stocks we like better.

Sepio Capital LP increased its stake in Dolby Laboratories (NYSE:DLB - Free Report) by 68.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,188 shares of the electronics maker's stock after purchasing an additional 7,403 shares during the quarter. Sepio Capital LP's holdings in Dolby Laboratories were worth $1,461,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in DLB. Alpine Bank Wealth Management purchased a new position in Dolby Laboratories during the 1st quarter valued at about $25,000. Cheviot Value Management LLC purchased a new position in Dolby Laboratories during the 1st quarter valued at about $27,000. MAI Capital Management grew its holdings in Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock valued at $28,000 after buying an additional 162 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Dolby Laboratories during the 1st quarter valued at about $29,000. Finally, Global X Japan Co. Ltd. purchased a new position in Dolby Laboratories during the 1st quarter valued at about $51,000. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Dolby Laboratories Stock Down 0.8%

Shares of NYSE DLB traded down $0.59 during trading hours on Friday, reaching $71.52. 90,482 shares of the stock traded hands, compared to its average volume of 430,848. The company has a market capitalization of $6.85 billion, a P/E ratio of 26.20 and a beta of 0.93. Dolby Laboratories has a 52-week low of $68.24 and a 52-week high of $89.66. The company's 50-day simple moving average is $73.81 and its two-hundred day simple moving average is $75.60.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. The company had revenue of $315.55 million for the quarter, compared to analysts' expectations of $305.23 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.Dolby Laboratories's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, sell-side analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a $0.33 dividend. The ex-dividend date was Tuesday, August 12th. This represents a $1.32 annualized dividend and a yield of 1.8%. Dolby Laboratories's payout ratio is presently 48.35%.

Analysts Set New Price Targets

Several analysts have weighed in on DLB shares. Tigress Financial raised their price target on Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a report on Friday, August 15th. Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Friday. Baird R W raised Dolby Laboratories to a "hold" rating in a report on Friday, September 5th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Finally, Robert W. Baird started coverage on Dolby Laboratories in a report on Friday, September 5th. They issued a "neutral" rating and a $74.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $95.75.

Check Out Our Latest Analysis on DLB

Insider Activity at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $72.31, for a total transaction of $1,807,750.00. Following the completion of the sale, the chief executive officer owned 114,725 shares of the company's stock, valued at approximately $8,295,764.75. This represents a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares in the company, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 99,366 shares of company stock valued at $7,352,963 in the last quarter. Corporate insiders own 38.39% of the company's stock.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.